SIStockInvestingSI.com

NYSE · DVA · Medical Care Facilities

DaVita Inc. (DVA) stock analysis

$176.81+0.83%Data as of Oct 21, 2026
  • DVA lost 3.8% over the past month versus 0.0% for the S&P 500, ranking 386th of 497 S&P 500 stocks.
  • Over 12 months it returned +38.1%, 22.3 points ahead of the S&P 500, and trades 26.6% below its 52-week high.
  • In the last 30 days 1 analyst raised earnings estimates and 0 cut; forward EPS moved −0.6% (−0.5% over 90 days).
  • It sits in the Hospitals & dialysis segment of the Medtech, Diagnostics & Care, where the 1-month median return is +2.0%.
  • The daily chart reads Trend transition · Unresolved structure (since Oct 20, 2026).
Market cap$11.3B
12-month return+38.1%
Forward P/E10.2×
Mean target vs price+24.3%

One-year price with 50- and 200-day averages

Open in Hub
115153192230JanAprJulOct
175.3550-day200-day

Performance vs the market

Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.

DVA−3.8%
Sector median−8.7%
S&P 5000.0%
DVA−24.5%
Sector median−5.4%
S&P 500+4.7%
DVA+16.0%
Sector median−1.5%
S&P 500+8.7%
DVA+38.1%
Sector median+1.7%
S&P 500+15.8%
1-month rank in the S&P 500386 / 497
3-month rank in its sector · Healthcare541 / 720

Chart structure

Read by our daily-bar structure engine from swing highs, swing lows and moving averages.

Trend transition · Unresolved structureAwaiting confirmation

Holding since Oct 20, 2026

  • Close below EMA20 below EMA50
  • EMA50 fell over the last ten sessions
  • Volume exceeds 1.5× the prior 20-session average; supporting evidence only
  • Neither a stable trend nor a range is confirmed
This pattern on this stock

79 occurrences in 10 years. The median move over the next 20 sessions was +1.1%, positive 56% of the time, against +0.8% for any day in the same period.

Reference zone, stop and targets for this structureSee the trade plan in Hub ↗

Analyst earnings revisions

Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.

Forward EPS$17.14
30-day change−0.6%
90-day change−0.5%
Mean target$219.86 +24.3%
Raised (30d) 1Cut (30d) 0

7 analysts cover the stock

Fundamental shape vs peers

Six dimensions on fixed scales. The filled shape is the company; the outline is the peer average.

Open the full Radar with every ratio
ValuationRevisionsMomentumGrowthCashProfit

Ahead of peersRevisions, Valuation

Behind peersMomentum

PeersHCA · THC · EHC · FMS

Where it sits in the supply chain

Medtech, Diagnostics & Care · Care delivery

Explore the full chain map in Hub
Supplied by
Surgical & interventional devices+2.3%
ISRG+6.5%1 monthSYK+8.5%1 monthBSX−0.9%1 monthMDT+3.3%1 monthEW−0.4%1 monthZBH+1.2%1 month
Supplies, sterilization & packaging+6.0%
BDX+6.2%1 monthWST+6.0%1 monthSOLV−2.3%1 monthBAX+4.3%1 monthSTE+6.1%1 month
Chronic care & home monitoring−0.7%
RMD+10.9%1 monthPODD+1.8%1 monthDXCM−10.4%1 monthABT−3.1%1 month
Vision & dental+2.7%
COO+6.7%1 monthALGN−1.3%1 month
Imaging & patient monitoring+4.1%
GEHC+4.1%1 month
Weight-loss drugs (GLP-1)+3.8%
LLY+8.6%1 monthNVO−0.9%1 month
Its segment
Hospitals & dialysis+2.0%
HCA+4.9%1 monthUHS+2.0%1 monthDVA−3.8%1 month

Care providers use equipment and services; labor and payer mix affect margins.

Sells into
Patients, insurers & government+11.0%
CNC+11.0%1 monthUNH+11.8%1 monthELV+7.9%1 month

Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps

Risk profile

Max drawdown, 12M−27.9%
Volatility, 60D47.3%
From 52-week high−26.6%
From 52-week low+70.2%
Trailing P/E15.0×
Forward P/E10.2×
UHSUniversal Health Services, Inc.ISRGIntuitive SurgicalSYKStrykerBSXBoston ScientificMDTMedtronicEWEdwards Lifesciences CorporatioZBHZimmer Biomet Holdings, Inc.BDXBecton, Dickinson and Company

Track this stock every day

Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.

Open in Hub ↗